BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 33466921)

  • 1. Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.
    Xia X
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33466921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
    Raghuvamsi PV; Tulsian NK; Samsudin F; Qian X; Purushotorman K; Yue G; Kozma MM; Hwa WY; Lescar J; Bond PJ; MacAry PA; Anand GS
    Elife; 2021 Feb; 10():. PubMed ID: 33554856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion.
    Barrett CT; Neal HE; Edmonds K; Moncman CL; Thompson R; Branttie JM; Boggs KB; Wu CY; Leung DW; Dutch RE
    J Biol Chem; 2021 Jul; 297(1):100902. PubMed ID: 34157282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 9. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles.
    Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C
    J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core.
    Pak AJ; Yu A; Ke Z; Briggs JAG; Voth GA
    Nat Commun; 2022 Feb; 13(1):1002. PubMed ID: 35194049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit.
    Asandei A; Mereuta L; Schiopu I; Park J; Seo CH; Park Y; Luchian T
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55649-55658. PubMed ID: 33270413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
    Ozono S; Zhang Y; Ode H; Sano K; Tan TS; Imai K; Miyoshi K; Kishigami S; Ueno T; Iwatani Y; Suzuki T; Tokunaga K
    Nat Commun; 2021 Feb; 12(1):848. PubMed ID: 33558493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
    Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
    Front Immunol; 2021; 12():613045. PubMed ID: 33841395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilizing the closed SARS-CoV-2 spike trimer.
    Juraszek J; Rutten L; Blokland S; Bouchier P; Voorzaat R; Ritschel T; Bakkers MJG; Renault LLR; Langedijk JPM
    Nat Commun; 2021 Jan; 12(1):244. PubMed ID: 33431842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novavax offers first evidence that COVID vaccines protect people against variants.
    Callaway E; Mallapaty S
    Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 51.